Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Psychological Well-Being 1Parasomnias 1Fatigue 1

Interventions

Fulvestrant 81Letrozole 74Paclitaxel 71pembrolizumab 67Specimen Handling 63Trastuzumab 60Carboplatin 55Magnetic Resonance Spectroscopy 50ribociclib 47Capecitabine 47Anastrozole 45palbociclib 44pertuzumab 43Tamoxifen 38Cyclophosphamide 38exemestane 37abemaciclib 37Biopsy 35trastuzumab deruxtecan 30Docetaxel 28Taxes 27Gemcitabine 25Radiotherapy 24Surveys and Questionnaires 23130-nm albumin-bound paclitaxel 23Standard of Care 21Blood Specimen Collection 21sacituzumab govitecan 20olaparib 20eribulin 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Relaxation Therapy × Breast × 90 days × Clear all
NCT06924788 2026-05-28

VSMART

University of Alabama at Birmingham

Phase NA Enrolling by invitation
25 enrolled
Breast

Breast Neoplasms

NCT01202851 2026-05-05

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
681 enrolled
Breast

Psychological Well-Being, Breast Neoplasms, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡